Press Releases

Approximately £1.7 billion committed to capacity buildout at four sites Growing commercial and AI R&D presence at London hub UK customers using Nebius include pioneers in financial services, healthcare and life sciences Nebius (NASDAQ:NBIS), the AI cloud company, today announced it is investing approximately £1.7 billion to build out capacity in the UK with three new deployments of NVIDIA infrastructure, as the company continues to expand its commercial and AI R&D hub in London. Nebius launched its first UK deployment of NVIDIA Blackwell Ultra infrastructure in November 2025. The three new sites will also deploy the latest generations of NVIDIA's full-stack, end-to-end AI factor

RIYADH, Saudi Arabia, June 08, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a global enterprise AI infrastructure and solutions provider, today announced the establishment of its regional headquarters in Riyadh, Saudi Arabia, reinforcing the company's long-term commitment to the Kingdom of Saudi Arabia and the broader Middle East region. The new regional headquarters will serve as a strategic hub for Rackspace Technology's operations and customer engagement efforts, supporting organizations across enterprise, government, and regulated industries as they accelerate digital transformation initiatives aligned with Saudi Arabia's Vision 2030 agenda. The Riyadh office will be

WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace First Quantum Security Service to Launch Within SEALCOIN's Dedicated Quantum Marketplace, Enabling Organizations to Assess and Prepare for Quantum-Era Cybersecurity Risks Geneva, Switzerland – June 8, 2026 — WISeKey International Holding Ltd ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and IoT, today announced the launch of a dedicated Quantum Marketplace within the SEALCOIN platform and the introduction of its flagship application, the QAIT Q-Day Security Assessment Platform. Developed in collaboration with The Hashgraph Group (THG)

Agreement offers potential best-in-class targeted protein degrader therapy option for people living with B-cell malignanciesCollaboration adds to Roche's oncology pipeline and offers potential indications in immunology (chronic spontaneous urticaria) and neurology (multiple sclerosis) Bexobrutideg utilises a novel approach to eliminate the Bruton's Tyrosine Kinase (BTK) protein, potentially overcoming existing resistance mechanisms found with current standard-of-care BTK inhibitors Basel, 08 June 2026 - Roche ((SIX: RO, ROP, OTCQX:RHHBY) announced today that it has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics, Inc. (NASDAQ:NRIX). Under the terms of

Strategic collaboration combines Nurix's leadership in targeted protein degradation with Roche's portfolio of B-cell targeted therapies and global clinical and commercialization footprint Robust clinical development plan in malignant hematology builds on the ongoing pivotal program in chronic lymphocytic leukemia (CLL) and includes therapeutic combination regimens across B cell malignancies Clinical development plan also includes expansion into neurology and immunology with plans for Phase 2 trials in multiple sclerosis (MS) and chronic spontaneous urticaria (CSU) Nurix to receive an upfront cash payment of $700 million and is eligible to receive development, regulatory and sales milesto

(From left to right) En. Wan Murdani, Senior Vice President, Malaysia Digital Economy Corporation (MDEC); Ms. Zuaida Abdullah, Deputy Chief Executive Officer, Investment Development, Malaysian Investment Development Authority (MIDA); YB Gobind Singh Deo, Minister of Digital; Serene Nah, Managing Director and Head of Asia Pacific, Digital Realty; Billy Lee, Chairman, CSF Advisers Sdn Bhd and Advisor for Malaysia, Digital Realty; and Govind Choudhary, General Manager, Southeast Asia and India, Digital Realty, at the inauguration of Digital Realty's Malaysia operations in Cyberjaya.  KUALA LUMPUR, Malaysia, June 08, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE:DLR), the world's largest cl

Most surveyed technology leaders are accountable for systems they don't fully controlOnly 11% of respondents say they're completely prepared for the scale of AI agent deploymentOrganizations that design control into their AI systems achieve significantly stronger performance outcomes.ARMONK, N.Y., June 8, 2026 /CNW/ -- A new IBM (NYSE:IBM) Institute for Business Value study reveals that as AI moves from experimentation to enterprise-wide deployment, two-thirds of surveyed CIOs and CTOs report being held accountable for AI systems they do not fully control, while governance struggles to keep pace at scale. The global study* of 2

Rumble Has Successfully Secured the Support of 85% of Northern Data's Share Capital In Total, 46% of Northern Data Shares not subject to Transaction Support Agreements Have Been Tendered Additional Acceptance Period Expired on June 1, 2026 – Exchange Offer No Longer Open for Acceptance Closing Expected in mid-June 2026, with application for Delisting of Northern Data Shares expected to be filed immediately Afterwards Transaction Follows Compelling Strategic Rationale Longboat Key, FL, June 08, 2026 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ:RUM) ("Rumble"), the Freedom-First technology platform, today announced the final results for its exchange offer to acquire all outstanding shares o

BitGo MENA FZE ("BitGo MENA"), a subsidiary of BitGo Holdings, Inc. (NYSE:BTGO) ("BitGo"), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA's established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA's Broker-Dealer license from Dubai's Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA's regulated product suite under VARA's oversight, marking another step in the region's continued buildout of institutional d

Proceeds fully fund the company through 2028 and will be used to accelerate commercialization of Solidion's patented Extreme-Climate Battery Technology targeting the Lunar economy and space applications DALLAS, TX, June 07, 2026 (GLOBE NEWSWIRE) -- Solidion Technology Inc. ("Solidion" or the "Company") (NASDAQ:STI), an advanced battery technology solutions provider, today announced that it has entered into a securities purchase agreement with a new institutional investor for the purchase and sale of 2,333,000 shares of common stock (or common stock equivalents) in a private placement priced above market under Nasdaq rules. The offering is expected to result in gross proceeds of $35 milli

FF will hold its FF EAI Robotics Education Ecosystem Strategy, Product Line & New EAI Device Launch at its Los Angeles headquarters on June 16, where the Company will give a full and in-depth introduction to FF's robotics education ecosystem strategy and also launch its EAI education product line and several major new EAI devices. On June 22, at Automate in Chicago, the largest robotics show in North America, FF will hold the FF EAI Robotics Multi-Form Lineup Debut & New Product Launch. FF will use this event to share more on its Three-in-One EAI ecosystem and EAI device lineup. Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or the "Company"), a Califo

SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (NASDAQ:LENZ, "LENZ" or the "Company")), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmic solution) 1.44%, the first and only aceclidine-based eye drop for the treatment of presbyopia, today announced that Everest Medicines (HKEX1952, or "Everest"), has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals ("CORXEL") to acquire the rights to develop, manufacture, and commercialize VIZZ (LNZ100) in Greater China, including Chinese mainland, Hong Kong SAR, Macao SAR, and Taiwan region. Everest Medicines is a biopharmaceutical company focused on discovering, developing

Ramat Gan, Israel, June 07, 2026 (GLOBE NEWSWIRE) -- Odysight.ai® (NASDAQ/TASE: ODYS) today announced that, as part of a planned step to expand the Company's financing toolkit in the U.S. capital market, it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (SEC) under which it may offer and sell from time to time and at its discretion shares of its common stock having an aggregate offering price of up to $20 million pursuant to an At-The-Market (ATM) program with the investment bank Roth Capital Partners. The program provides the Company with an additional, flexible financing infrastructure that can be utilized at the Company's discretion to support busines

News Summary: SK Telecom plans to build a gigawatt-scale AI Cloud in Korea using the NVIDIA DSX platform, with the first AI factory planned to come online in 2027.The AI Cloud will support sovereign, physical and agentic AI services for enterprises and industries across Korea, building on SK Telecom's network, data center and enterprise infrastructure expertise.NVIDIA DSX will serve as the AI factory architecture blueprint, combining NVIDIA accelerated computing, systems, software and partner technologies to improve time to production and token performance per megawatt.NVIDIA and SK Group are planning to expand their collaboration from AI infrastructure deployments to joint research on next

News Summary: NAVER, an AI Cloud, will build AI factories on the NVIDIA DSX platform at gigawatt scale, starting with AI infrastructure expansion at GAK Sejong.NVIDIA DSX gives NAVER a proven AI factory blueprint to serve Korea's industries and global AI cloud customers as demand for useful AI surges at lowest token cost.NAVER will use NVIDIA full-stack AI platforms, models and software to advance regional AI models including next-generation HyperCLOVA X models, its Seoul World Model development and agentic AI services. SEOUL, South Korea, June 07, 2026 (GLOBE NEWSWIRE) -- NVIDIA and NAVER today announced that NAVER will expand sovereign AI infrastructure, starting at 55 megawatts with p

News Summary: NVIDIA and SK hynix announce multiyear technology partnership for next-generation memory aligned to NVIDIA's AI infrastructure roadmap.The agreement supports supply for advanced memory, addressing the extended development cycles, advanced fabrication and capital investments to sustain the global buildout of AI factories.SK hynix will diversify into new markets NVIDIA is creating — across AI infrastructure, personal AI and physical AI — codeveloping memory for NVIDIA Vera Rubin AI supercomputers, Vera CPUs, RTX Spark-powered PCs and Jetson Thor robotic computing platforms.The two companies will apply AI to semiconductor chip design and manufacturing, using NVIDIA CUDA-X librari

$4.6 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the full exercise of warrantsHENDERSON, Nev., June 7, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announced the pricing of its previously announced public offering of 2,960,000 shares of common stock, and warrants to purchase up to an aggregate of 1,480,000 shares of common stock, at a combined public offering price of $1.55 per share and accompanying half warrant. Each warrant will have an exercise price of $1.55 per share, will be exercisable immediately upon issuance, and will expire five years after the date of issuance. T

VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk DiabetesNew Real-World Data Highlight Treatment Gaps in Current Obesity and Diabetes CareTHOUSAND OAKS, Calif., June 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data at the American Diabetes Association (ADA) 86th Scientific Sessions reinforcing its commitment to addressing unmet needs for people living with cardiometabolic conditions and improving patient outcomes.The data include new Phase 3 VESALIUS-CV subgroup results for Repatha® in patients with high-risk diabetes (microvascular disease, insulin use or diabetic duration ≥10 years) and e

Initiates voluntary prepackaged Chapter 11 process to implement Restructuring Transactions that have the support of 100% of its lenders, over 60% of the holders of GoHealth, Inc. Class A Common Stock, and over 99% of the holders of GoHealth Holdings, LLC interests. Plans to continue operations without interruption and it is business-as-usual for the Company in providing service for existing Medicare consumers and partners. CHICAGO, June 07, 2026 (GLOBE NEWSWIRE) -- GoHealth, Inc. ("GoHealth" or the "Company"), a health insurance marketplace and Medicare-focused digital health company, announced that GoHealth and certain of its subsidiaries have voluntarily filed chapter 11 petitions (the

Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP-1 dual agonist, from baseline.1 ​ Detailed pre-specified analysis from a sub study of SYNCHRONIZE-1 show that, relative to baseline, survodutide achieved a reduction of up to 34% in visceral fat, with